Results 21 to 30 of about 11,804,890 (262)

On Diseased Conditions of the Knee-Joint [PDF]

BMJ
W. P. Swain
  +21 more sources

Bumpy road on a way to diagnose sarcoidosis

Liječnički vjesnik, 2023
Sarcoidosis is a systemic disease with unknown etiology characterized by noncaseating granulomas in any organ, most commonly the lungs and intrathoracic lymph nodes.
Maro Brbora, Marcela Babić, Marija Gomerčić Palčić   +2 more
doaj   +1 more source

Impact of the COVID-19 pandemic on morbidity and mortality in patients with inflammatory joint diseases and in the general population: a nationwide Swedish cohort study

Annals of the Rheumatic Diseases, 2021
Objectives To estimate absolute and relative risks for all-cause mortality and for severe COVID-19 in inflammatory joint diseases (IJDs) and with antirheumatic therapies.
H. Bower, T. Frisell, D. di Giuseppe, B. Delcoigne, Gerd-Marie Ahlénius, E. Baecklund, K. Chatzidionysiou, N. Feltelius, H. Forsblad-d’Elia, A. Kastbom, Lars Klareskog, E. Lindqvist, U. Lindström, C. Turesson, C. Sjöwall, J. Askling   +15 more
semanticscholar   +1 more source

Inflammatory Joint Diseases [PDF]

BioMed Research International, 2015
Arthritis is a common clinical manifestation of rheumatic diseases. It can be a clinical feature in many rheumatic diseases, including rheumatoid arthritis, spondyloarthritis, crystal-induced arthritis, systemic lupus erythematosus, and Sjogren's syndrome. Joint inflammation and damage may result in disability and morbidity.
Guixiu Shi, Julian L. Ambrus, Shuang Ye, Long Shen   +3 more
openaire   +2 more sources

Human Mesenchymal Stem Cell‐Derived Miniature Joint System for Disease Modeling and Drug Testing

Advanced Science, 2022
Diseases of the knee joint such as osteoarthritis (OA) affect all joint elements. An in vitro human cell‐derived microphysiological system capable of simulating intraarticular tissue crosstalk is desirable for studying etiologies/pathogenesis of joint ...
Zhong Li, Zixuan Lin, Silvia Liu, Haruyo Yagi, Xiurui Zhang, Lauren Yocum, Monica Romero‐Lopez, Claire Rhee, Meagan J. Makarcyzk, Ilhan Yu, Eileen N. Li, Madalyn R. Fritch, Qi Gao, Kek Boon Goh, Benjamen O'Donnell, Tingjun Hao, Peter G. Alexander, Bhushan Mahadik, John P. Fisher, Stuart B. Goodman, Bruce A. Bunnell, Rocky S. Tuan, Hang Lin   +22 more
doaj   +1 more source

Joint status and related risk factors in patients with severe hemophilia A: a single-center cross-sectional study

Hematology, 2022
Objectives Hemophilic arthropathy is the most common complication of severe hemophilia A. This study aims to investigated joint status and related risk factors in patients with severe hemophilia A (PWSHA).
Liang Zhao, Hongbin Yang, Yaochun Li, Zhongqing Wang, Li Zhou, Xielan Zhao, Jie Peng   +6 more
doaj   +1 more source

Current Trends in Improving of Artificial Joints Design and Technologies for Their Arthroplasty [PDF]

, 2020
There is a global tendency to rejuvenate joint diseases, and serious diseases such as arthrosis and arthritis develop in 90% of people over 55 years of age.
Pakhaliuk, Vladimir, Poliakov, Aleksandr, Popov, Valentin L.   +2 more
core   +1 more source

Diseases of Old Age in Two Paintings by Rembrandt [PDF]

Rambam Maimonides Medical Journal, 2015
Two paintings of older men by Rembrandt (1609–1669) are examined to demonstrate that historical attitudes toward diseases of old age and the ageing person’s response to illness can be investigated in paintings.
George M. Weisz, William R. Albury
doaj   +1 more source

Role of Signal Transduction Pathways and Transcription Factors in Cartilage and Joint Diseases

International Journal of Molecular Sciences, 2020
Osteoarthritis and rheumatoid arthritis are common cartilage and joint diseases that globally affect more than 200 million and 20 million people, respectively.
R. Nishimura, K. Hata, Y. Takahata, Tomohiko Murakami, Eriko Nakamura, Maki Ohkawa, Lerdluck Ruengsinpinya   +6 more
semanticscholar   +1 more source

Cost analysis of hemophilia treatment in a Brazilian public blood center

Cadernos de Saúde Coletiva, 2020
Background hemophilia is a rare coagulopathy, treated by replacing the missing blood clotting factor. Objective to assess the direct costs of hemophilia treatment from the perspective of the Unified Health System, highlighting the impact costs of new ...
Adriana Aparecida Ferreira, Igor Vilela Brum, João Vítor de Lanna Souza, Isabel Cristina Gonçalves Leite   +3 more
doaj   +1 more source